Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MX:ONCN
Stock Latest News
The Fly
BeOne Medicines price target raised to $415 from $407 at Barclays
10d ago
ONC
Premium
The Fly
BeOne Medicines to expand access to cancer medicines under pact with U.S.
19d ago
ONC
Premium
The Fly
BeOne Medicines announces new Phase 3 survival data on Ziihera
20d ago
ONC
Premium
The Fly
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
26d ago
ONC
JAZZ
Premium
The Fly
Zymeworks says partner Jazz receives FDA approval for Ziihera regimens
26d ago
ONC
JAZZ
Premium
The Fly
BeOne Medicines renews partnerships to expand access to Brukinsa in leukemia
1M ago
ONC
Premium
Company Announcements
BeOne Medicines Earnings Call Signals Robust Growth
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $370 from $340 at Wolfe Research
1M ago
ONC
Premium
The Fly
BeOne Medicines partners with Revolution Medicines for clinical development
1M ago
ONC
RVMD
Premium
The Fly
BeOne Medicines price target raised to $405 from $395 at Morgan Stanley
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $454 from $424 at TD Cowen
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $418 from $416 at Truist
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $430 from $420 at Guggenheim
1M ago
ONC
Premium
The Fly
BeOne Medicines price target lowered to $450 from $451 at RBC Capital
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $466 from $453 at Citi
1M ago
ONC
Premium
Ratings
Analyst Lifts BeOne Medicines Price Target to $466 on Robust BRUKINSA Growth and Pipeline Milestones
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $405 from $396 at Citizens
1M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $407 from $403 at Barclays
1M ago
ONC
Premium
Ratings
BeOne Medicines: Buy Rating Reiterated on Strong Q2 Beat, Raised 2026 Outlook and Unchanged $395 Price Target
2M ago
ONC
Premium
The Fly
BeOne Medicines reports Q2 adjusted EPS $3.84, consensus $1.63
2M ago
ONC
Premium
The Fly
BeOne Medicines raises FY26 revenue view to $6.6B-$6.8B from $6.3B-$6.5B
2M ago
ONC
Premium
Pre-Earnings
ONC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ONC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
